Including Measures of Chronic Kidney Disease to Improve Cardiovascular Risk Prediction by SCORE2 and SCORE2-OP.
Kunihiro MatsushitaStephen KaptogeSteven H J HagemanYingying SangShoshana H BallewMorgan E GramsAditya SurapaneniLuanluan SunJohan ArnlovMilica BozicHermann BrennerNigel J BrunskillAlex R ChangRajkumar ChinnaduraiMassimo CirilloAdolfo CorreaNatalie EbertKai Uwe EckardtRon T GansevoortOrlando GutierrezFarzad HadaeghJiang HeShih-Jen HwangTazeen H JafarSimerjot K JassalTakamasa KayamaCsaba P KovesdyGijs W LandmanAndrew S LeveyDonald M Lloyd-JonesRupert W MajorKatsuyuki MiuraPaul MuntnerGirish N NadkarniChristoph NowakTakayoshi OhkuboMichelle J PenaKevan R PolkinghorneToshimi SairenchiElke SchaeffnerMarkus P SchneiderVarda ShalevMichael G ShlipakMarit D SolbuNikita StempniewiczJames TollittJosé M ValdivielsoJoep van der LeeuwAngela Yee Moon WangChi Pang WenMark WoodwardKazumasa YamagishiHiroshi YatsuyaLuxia ZhangJannick A N DorresteijnEmanuele Di AngelantonioFrank Lj VisserenLisa PennellsJosef Coreshnull nullPublished in: European journal of preventive cardiology (2022)
Our Add-ons with CKD measures improved CVD risk prediction beyond SCORE2 and SCORE2-OP. This approach will help clinicians and patients with CKD refine risk prediction and further personalize preventive therapies for CVD.